Prevention of Delirium in Inpatients Utilizing Melatonin

NCT02654314 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

277

Enrollment

OTHER

Sponsor class

Stopped Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.

Conditions

Delirium

Interventions

DRUG: Melatonin
OTHER: Placebo

Sponsor

Yale University